Matthews Judith M. 4
4 · Iterum Therapeutics plc · Filed Apr 3, 2023
Insider Transaction Report
Form 4
Matthews Judith M.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-03-31+100,000→ 100,000 totalExercise: $1.00Exp: 2033-03-30→ Ordinary Shares (100,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option shall vest at a rate of 33.3% of the total number of shares on the one-year anniversary of March 31, 2023 and the remaining 66.7% will vest in equal monthly installments thereafter until March 31, 2026, subject to the Reporting Person providing continuous service to the Issuer on each relevant vesting date.